SEDLine™, Inc., announced today that it has acquired the brain function
monitoring business of Hospira, Inc. (NYSE:HSP). Privately held and
backed with an investment from Masimo Corporation (NASDAQ:MASI),
SEDLine, Inc., based in Irvine, California, was formed with the mission
to advance neuromonitoring technologies to improve the care of patients
under anesthesia or sedation.
“Improving Patient Outcomes and Reducing Cost of Care by Taking
Noninvasive Monitoring to New Sites and Applications.”
Brain function monitoring (BFM) has become a widely utilized modality
for assessing depth of anesthesia and sedation. Based primarily on
analysis of the electroencephalogram (EEG), brain function monitors
continuously measure the electrical activity of the brain and translate
those changes to the level of consciousness. BFM has been deployed in a
variety of clinical environments, ranging from the operating room for
patients having surgery, to intensive care units where critically ill
patients can be sedated for prolonged periods, and in short procedure
units where patients undergo procedures such as colonoscopy and
endoscopy.
SEDLine’s technology is based on 10 years of innovation and offers a
cost-effective alternative to other monitors, while delivering proven
4-channel EEG integrated algorithm performance, demonstrated reliability
under challenging clinical conditions and superior resistance to cautery.